It is of note that GRS was not associated with any confounder (i.e. age at recruitment, sex, smoking habits, BMI, HbA1c, anti-hypertension and anti-dyslipidemia therapies) we accounted for, when testing the association between resistin and mortality rate (p values ranging from 0.13 to 0.64). Here, RETN is linked to metabolic syndrome.